Parabilis Medicines, Inc. (PBLS)
NASDAQ: PBLS · Real-Time Price · USD
25.85
-0.18 (-0.69%)
At close: Jun 18, 2026, 4:00 PM EDT
25.92
+0.07 (0.27%)
After-hours: Jun 18, 2026, 7:58 PM EDT
Parabilis Medicines Market Cap
Parabilis Medicines has a market cap or net worth of $3.29 billion as of June 18, 2026.
Market Cap
3.29B
Enterprise Value
3.06B
1-Year Change
n/a
Ranking
Category
Stock Price
$25.85
Market Cap Chart
Since the IPO on June 10, 2026, Parabilis Medicines's market cap has increased from $2.38B to $3.29B, an increase of 38.60%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 18, 2026 | 3.29B | -0.69% |
| Jun 17, 2026 | 3.31B | -2.11% |
| Jun 16, 2026 | 3.39B | 6.32% |
| Jun 15, 2026 | 3.18B | -8.25% |
| Jun 12, 2026 | 3.47B | -3.07% |
| Jun 11, 2026 | 3.58B | 50.78% |
| Jun 10, 2026 | 2.38B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Crinetics Pharmaceuticals | 3.69B |
| Edgewise Therapeutics | 3.65B |
| ACADIA Pharmaceuticals | 3.59B |
| NewAmsterdam Pharma Company | 3.53B |
| Denali Therapeutics | 3.48B |
| Viking Therapeutics | 3.44B |
| Telix Pharmaceuticals | 3.32B |
| Relay Therapeutics | 3.28B |